Tay-Sachs disease is a rare, inherited disorder that progressively destroys nerve cells in the brain and spinal cord. It is caused by a deficiency of an enzyme called hexosaminidase A, which is necessary for the normal breakdown of a fatty substance called ganglioside GM2. When this substance accumulates to high levels in the brain, it leads to the death of nerve cells.

There are several types of Tay-Sachs disease, including classic, late-onset, and juvenile forms. Classic Tay-Sachs disease: This is the most severe form of the disorder and typically occurs in infants between the ages of 3 and 6 months. Symptoms include a lack of muscle tone, difficulty sucking and swallowing, developmental delays, and a cherry-red spot in the center of the eye. As the disease progresses, infants may experience seizures, blindness, and deafness. Most children with classic Tay-Sachs disease do not survive beyond age 5. Late-onset Tay-Sachs disease: This form of the disorder typically occurs in individuals between the ages of 1 and 2 years and is less severe than the classic form. Symptoms may include developmental delays, muscle weakness, and difficulty walking. Juvenile Tay-Sachs disease: This form of the disorder typically occurs in children between the ages of 2 and 5 years and is less severe than the classic form. Symptoms may include muscle weakness, difficulty walking, and developmental delays. Children with juvenile Tay-Sachs may survive into adulthood, but may have severe physical and cognitive disabilities.

Tay-Sachs is caused by a deficiency of an enzyme called hexosaminidase A, which is responsible for breaking down a fatty substance called ganglioside GM2. When this enzyme is lacking, the ganglioside accumulates in the brain and nerve cells, leading to the death of these cells and the development of neurological symptoms. The deficiency of hexosaminidase A is caused by a genetic mutation on chromosome 15.

Tay-Sachs is typically diagnosed through a combination of genetic testing, physical examination, and medical history. • Genetic testing: This involves taking a sample of blood or saliva and analyzing it for genetic mutations associated with Tay-Sachs. • Physical examination: A healthcare provider will examine the patient for physical signs and symptoms of Tay-Sachs disease, such as muscle weakness, developmental delays, and abnormal eye movements. • Medical history: The healthcare provider will ask about the patient’s medical history and family history. If the patient is suspected to have Tay-Sachs, a more definitive diagnosis may be made through a lumbar puncture (also known as a spinal tap) or brain imaging tests, such as an MRI or CT scan.

There is no cure for Tay-Sachs disease, and treatment is mainly supportive and focuses on managing symptoms and providing comfort. This may include medications to reduce seizures, physical therapy to maintain muscle strength, and feeding tubes to provide nutrition. Palliative care, which is focused on providing comfort and improving quality of life, is also an important aspect of treatment for individuals with Tay-Sachs.